Uterine leiomyosarcoma: Does the primary surgical procedure matter?

International Journal of Gynecological Cancer

Volumn 19, Issue 2, 2009, Pages 257-260

  Perri, Tamar ^a,c   Korach, Jacob ^a   Sadetzki, Siegal ^b   Oberman, Bernice ^b   Fridman, Eddie ^c   Ben Baruch, Gilad ^a  

^a Department of Gynecological Oncology ^*  (Canada)

^b GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

Leiomyosarcoma; Prognosis; Stage I; Surgery

Indexed keywords

DOXORUBICIN;

ADJUVANT THERAPY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; KAPLAN MEIER METHOD; LAPAROSCOPIC SURGERY; MENOPAUSE; MYOMECTOMY; PARITY; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SCALPEL; SURGICAL TECHNIQUE; SURVIVAL RATE; UTERUS LEIOMYOSARCOMA; UTERUS SARCOMA; LEIOMYOSARCOMA; METHODOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; UTERUS CANCER;

ADULT; AGED; FEMALE; HUMANS; HYSTERECTOMY; LEIOMYOSARCOMA; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; UTERINE NEOPLASMS;

EID: 85047681250     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e31819a1f8f     Document Type: Article

References (27)

1. Olah KS, Dunn JA, Gee H. Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors: the result of a retrospective study of 423 cases of uterine sarcoma. Br J Obstet Gynaecol. 1992;99:590-594.
2. Giuntoli RL II, Metzinger DS, DiMarco CS, et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol. 2003;89:460-469.
3. Hsieh CH, Lin H, Huang CC, et al. Leiomyosarcoma of the uterus: a clinicopathologic study of 21 cases. Acta Obstet Gynecol Scand. 2003;82:74-81.
4. Wu TI, Chang TC, Hsueh S, et al. Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma. Gynecol Oncol. 2006;100:166-172.
5. Aviram R, Ochshorn Y, Markovitch O, et al. Uterine sarcomas versus leiomyomas: gray-scale and Doppler sonographic findings. J Clin Ultrasound. 2005;33:10-13.
6. Gojnic M, Likic I, Pervulov M, et al. The significance of Doppler flow in early detection of uterine sarcoma in older primigravida pregnancies. Eur J Gynaecol Oncol. 2005;26:291-293.
7. Kido A, Togashi K, Koyama T, et al. Diffusely enlarged uterus: evaluation with MR imaging. Radiographics. 2003;23:1423-1439.
8. Fukunishi H, Funaki K, Ikuma K, et al. Unsuspected uterine leiomyosarcoma: magnetic resonance imaging findings before and after focused ultrasound surgery. Int J Gynecol Cancer. 2007;17:724-728.
9. Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol. 1994;18:535-558.
10. Major FJ, Blessing JA, Silverberg SG, et al. Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study. Cancer. 1993;71:1702-1709.
11. Dinh TA, Oliva EA, Fuller AF Jr, et al. The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital. Gynecol Oncol. 2004;92:648-652.
12. Morice P, Rodriguez A, Rey A, et al. Prognostic value of initial surgical procedure for patients with uterine sarcoma: analysis of 123 patients. Eur J Gynaecol Oncol. 2003;24:237-240.
13. Einstein MH, Barakat RR, Chi DS, et al. Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease. Int J Gynecol Cancer. 2008;18:1065-1070.
14. Bradley WH, Boente MP, Brooker D, et al. Hysteroscopy and cytology in endometrial cancer. Obstet Gynecol. 2004;104:1030-1033.
15. Obermair A, Geramou M, Gucer F, et al. Does hysteroscopy facilitate tumor cell dissemination? Incidence of peritoneal cytology from patients with early stage endometrial carcinoma following dilatation and curettage (D & C) versus hysteroscopy and D & C. Cancer. 2000;88:139-143.
16. Sainz de la Cuesta R, Espinosa JA, Crespo E, et al. Does fluid hysteroscopy increase the stage or worsen the prognosis in patients with endometrial cancer? A randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2004;115:211-215.
17. Revel A, Tsafrir A, Anteby SO, et al. Does hysteroscopy produce intraperitoneal spread of endometrial cancer cells? Obstet Gynecol Surv. 2004;59:280-284.
18. Hansen NM, Ye X, Grube BJ, et al. Manipulation of the primary breast tumor and the incidence of sentinel node metastases from invasive breast cancer. Arch Surg. 2004;139:634-639;[discussion 639-640].
19. Martin RC II, Scoggins CR, Ross MI, et al. Is incisional biopsy of melanoma harmful? Am J Surg. 2005;190:913-917.
20. Mutter D, Hajri A, Tassetti V, et al. Increased tumor growth and spread after laparoscopy vs laparotomy: influence of tumor manipulation in a rat model. Surg Endosc. 1999;13:365-370.
21. Hirota M, Shimada S, Yamamoto K, et al. Pancreatectomy using the no-touch isolation technique followed by extensive intraoperative peritoneal lavage to prevent cancer cell dissemination: a pilot study. JOP. 2005;6:143-151.
22. Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232:10-24.
23. Migdal C. Effect of the method of enucleation on the prognosis of choroidal melanoma. Br J Ophthalmol. 1983;67:385-388.
24. Donnez O, Jadoul P, Squifflet J, et al. Iatrogenic peritoneal adenomyoma after laparoscopic subtotal hysterectomy and uterine morcellation. Fertil Steril. 2006;86:1511-1512.
25. Sinha R, Sundaram M, Mahajan C, et al. Multiple leiomyomas after laparoscopic hysterectomy: report of two cases. J Minim Invasive Gynecol. 2007;14:123-127.
26. Rougraff BT, Davis K, Cudahy T. The impact of previous surgical manipulation of subcutaneous sarcoma on oncologic outcome. Clin Orthop Relat Res. 2005;438:85-91.
27. Gustafson P, Dreinhofer KE, Rydholm A. Soft tissue sarcoma should be treated at a tumor center. A comparison of quality of surgery in 375 patients. Acta Orthop Scand. 1994;65:47-50.